Loading...
INOVIQ Ltd
IIQ.AX•ASX
HealthcareMedical - Diagnostics & Research
A$0.45
A$0.01(3.45%)
INOVIQ Ltd (IIQ.AX) Financial Performance & Statements
Review INOVIQ Ltd’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns to understand its financial health and growth.
Revenue Growth
34.39%
↑ 34.39%
Operating Income Growth
24.76%
↑ 24.76%
Net Income Growth
26.92%
↑ 26.92%
Operating Cash Flow Growth
38.46%
↑ 38.46%
Operating Margin
-510.68%
↓ 510.68%
Gross Margin
-99.73%
↓ 99.73%
Net Profit Margin
-323.03%
↓ 323.03%
ROE
-35.86%
↓ 35.86%
ROIC
-57.10%
↓ 57.10%
INOVIQ Ltd (IIQ.AX) Financial Statements
Explore quarterly and annual reports including balance sheet, income statement, cash flow for INOVIQ Ltd stock.
| Metric | Q4 2024 | Q2 2024 | Q4 2023 | Q3 2023 |
|---|---|---|---|---|
| Revenue | $1.36M | -$828388.00 | $233803.00 | $693406.00 |
| Cost of Revenue | $2.76M | -$1.24M | $20316.00 | $1.62M |
| Gross Profit | -$1.40M | $410542.00 | $213487.00 | -$928987.00 |
| Gross Profit Ratio | -$1.03 | -$1.85 | $0.91 | -$1.34 |
| R&D Expenses | $1.46M | $1.24M | $1.60M | $799127.00 |
| SG&A Expenses | $2.87M | $770369.00 | $2.91M | $1.46M |
| Operating Expenses | $4.33M | $2.48M | $4.51M | $847249.00 |
| Total Costs & Expenses | $7.09M | $1.24M | $4.53M | $2.47M |
| Interest Income | $213378.00 | $43203.00 | $169791.00 | $84896.00 |
| Interest Expense | $81532.00 | -$81532.00 | $0.00 | $0.00 |
| Depreciation & Amortization | $584086.00 | $619904.00 | $279684.00 | $456648.00 |
| EBITDA | -$3.91M | -$2.72M | -$4.10M | -$1.30M |
| EBITDA Ratio | -$2.87 | -$12.40 | -$6.33 | -$1.88 |
| Operating Income | -$5.73M | -$2.11M | -$4.30M | -$1.76M |
| Operating Income Ratio | -$4.20 | -$14.65 | -$18.38 | -$2.54 |
| Other Income/Expenses (Net) | -$2.17M | $3.45M | $194387.00 | $68130.00 |
| Income Before Tax | -$7.90M | $1.35M | -$4.10M | -$1.69M |
| Income Before Tax Ratio | -$5.79 | -$12.25 | -$17.55 | -$2.44 |
| Income Tax Expense | -$4.47M | $4.47M | -$720603.00 | $0.00 |
| Net Income | -$3.43M | -$3.13M | -$3.38M | -$1.69M |
| Net Income Ratio | -$2.51 | -$12.25 | -$14.47 | -$2.44 |
| EPS | -$0.04 | -$0.03 | -$0.04 | -$0.02 |
| Diluted EPS | -$0.04 | -$0.03 | -$0.04 | -$0.02 |
| Weighted Avg Shares Outstanding | $92.83M | $92.83M | $92.02M | $91.95M |
| Weighted Avg Shares Outstanding (Diluted) | $92.83M | $92.83M | $92.02M | $92.02M |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan